VEGFA and neoplasm: Gavilando et al. showed decreased tumor growth using six immunizations and three different adjuvants over 36 days following inoculation of mice with cancer cells (11), and Wang et al. showed decreased tumor growth using four immunizations with a VEGF peptide vaccine conjugated to measles virus fusion protein over 45 days after inoculation of mice with cancer cells (28).